#1
#1 out of 2
health5h ago
UK scientists developing Ebola vaccine that could be ready for trials in months
- Oxford University researchers are developing an Ebola vaccine that could begin clinical trials in two to three months.
- The outbreak centers on the Democratic Republic of Congo, with 750 suspected cases and 177 deaths.
- The vaccine targets Bundibugjo Ebola, a rare strain with no proven vaccine.
- The UK team uses a ChAdOx1 platform, a technology refined during the Covid-19 pandemic.
- Animal testing is underway in Oxford to gather data on safety and efficacy.
- The Serum Institute of India is lined up to mass produce the vaccine once material is ready.
- World Health Organization has upgraded the outbreak risk to very high in the DRC.
- Bundibugoro vaccination uses ring vaccination to protect those most at risk.
- Oxford researchers are building on prior work against Sudan Ebola and Marburg viruses.
- The WHO declared a public health emergency of international concern earlier this week.
Vote 0
